Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 4 días · Dive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy production. Merck KGaA is making the purchase through its U.S. and Canadian life sciences unit, MilliporeSigma.

  2. Hace 4 días · Merck KGaA and its CDMO arm MilliporeSigma are increasing their presence in gene therapy manufacturing with a $600 million buyout of Mirus Bio.

  3. Hace 4 días · See you at BIO: Chi­na ten­sions, fix­ing gene ther­a­py’s busi­ness mod­el, and the stop-start mar­ket re­cov­ery. Drew Armstrong Executive Editor. In two weeks, ...

  4. Hace 4 días · Oct. 14, 2019 — Scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia (FTD), adding to growing evidence that the ...

  5. Hace 5 días · Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

  6. Hace 5 días · Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to develop one or even a handful of world-changing drugs to address ...

  7. www.sciencedaily.com › news › health_medicineGenes News -- ScienceDaily

    Hace 5 días · New 'Atlas' Provides Unprecedented Insights on How Genes Function in Early Embryo Development. May 23, 2024 — Biologists have provided new insights on a longstanding puzzle in biology: How ...